Invus

Activity from announced rounds

Activity in this selectionAI

Invus is the investment-firm name used by Encoded Therapeutics and in LifeMine transaction-counsel coverage.

Recorded funding activity

Encoded develops precision gene therapies for neurological disorders. LifeMine uses fungal genomes for drug discovery, while City develops RNA-interference medicines. The records identify different therapeutic approaches without substituting an unnamed parent or fund.

Sources
Rounds participated in
1
Confirmed lead rounds
—
1 roles undisclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
—
0 disclosed · full round size, not this investor’s share

By stage

Undisclosed1

By primary sector

Robotics1

By country

United States1

Rounds

1 in this selection
Flexiv

Develops and manufactures adaptive robots for complex tasks

UndisclosedStrategic
Role not disclosed